|
Systemic Lupus Erythematosus and Autoimmunity
Citations 381-390 of 461 total displayed.
|
Past content
(since Jan 2000):
|
- Original Papers
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients
- R. Gerli, L. Caponi, A. Tincani, R. Scorza, M. G. Sabbadini, M. G. Danieli, V. De Angelis, M. Cesarotti, M. Piccirilli, R. Quartesan, P. Moretti, C. Cantoni, F. Franceschini, I. Cavazzana, L. Origgi, M. Vanoli, E. Bozzolo, L. Ferrario, A. Padovani, O. Gambini, L. Vanzulli, D. Croce, and S. Bombardieri
Rheumatology 2002; 41: 1357-1366.
[Abstract]
[Full Text]
- Original Papers
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality
- A. Jönsen, A. A. Bengtsson, O. Nived, B. Ryberg, and G. Sturfelt
Rheumatology 2002; 41: 1308-1312.
[Abstract]
[Full Text]
- Letters to the Editor
A rare cause of rash, eosinophilia and asthma in rheumatology
- J. Barber and P. Dawes
Rheumatology 2002; 41: 1329.
[Extract]
[Full Text]
- Review
Long-term complications of systemic lupus erythematosus
- C. Gordon
Rheumatology 2002; 41: 1095-1100.
[Extract]
[Full Text]
- Original Papers
Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999
- J. R. MacGowan, S. Ellis, M. Griffiths, and D. A. Isenberg
Rheumatology 2002; 41: 981-987.
[Abstract]
[Full Text]
- Original Papers
Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis
- J. T. Cvetkovic, S. Wållberg-Jonsson, E. Ahmed, S. Rantapää-Dahlqvist, and A. K. Lefvert
Rheumatology 2002; 41: 988-995.
[Abstract]
[Full Text]
- Reviews
HLA B27 in health and disease: a double-edged sword?
- P. Bowness
Rheumatology 2002; 41: 857-868.
[Abstract]
[Full Text]
- Original Papers
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents
- M. Y. Karim, P. Alba, M.-J. Cuadrado, I. C. Abbs, D. P. D'Cruz, M. A. Khamashta, and G. R. V. Hughes
Rheumatology 2002; 41: 876-882.
[Abstract]
[Full Text]
- Original Papers
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years
- G. F. Ferraccioli, E. Gremese, P. Tomietto, G. Favret, R. Damato, and E. Di Poi
Rheumatology 2002; 41: 892-898.
[Abstract]
[Full Text]
- Original Papers
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
- D. Erkan, Y. Yazici, M. G. Peterson, L. Sammaritano, and M. D. Lockshin
Rheumatology 2002; 41: 924-929.
[Abstract]
[Full Text]
|
|
